# Avance Nerve Graft

NDC: 84545-115
Generic name: Processed nerve allograft
Labeler / Manufacturer: Axogen Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: IMPLANT
Routes: SOFT TISSUE
Marketing started: 20260406

FDA application: BLA125816

## Active ingredients

- HUMAN PERIPHERAL NERVE TISSUE: 1 mm/15mm

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84545-115"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84545-115
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e50d90fa-83ef-4d1b-9691-2b9c7bbdc2ae